Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
RPTH Journal
Mar 20, 2026, 17:07

The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH

Research and Practice in Thrombosis and Haemostasis (RPTH) shared a post on LinkedIn about a recent article by Deepa Gautam, adding:

“Are all platelets the same?

Or are we missing critical biology hiding in plain sight?

We still rely on platelet count and MPV in both research and the clinic.

But this study shows that platelets are far from uniform and that heterogeneity systematically shifts across disease states.

Here’s what this paper delivers.

Using a 12-marker spectral flow cytometry panel pus high – dimensional clustering (PlateletProfiler), the authors map platelet states at single – cell resolution.

Platelets exist along an activation continuum, not just ‘resting vs activated’:

  • Resting
  • Primed
  • Aggregatory
  • Procoagulant

Disease reshapes platelet composition across models:

  • Inflammation (LPS) – expansion of primed plus aggregatory platelets
  • Jak2V617F (MPN) – increase in aggregatory plus procoagulant platelets
  • Cancer – enrichment of procoagulant platelets

Key mechanistic signal, all models showed:

  • Increased reticulated (young) platelets
  • Upregulation of activation plus immune markers (e.g., PD-L1, CD154)

This suggests:

  • Accelerated thrombopoiesis
  • Functionally ‘pre-activated’ circulating platelets
  • A link between platelet biology and immune modulation

Why this matters

We’ve been treating platelets as a homogeneous population.

This framework opens the door to:

  • Subpopulation-specific biomarkers
  • More precise antiplatelet strategies
  • Better mechanistic links between platelets, inflammation, and cancer”

Title: Characterizing mouse platelet heterogeneity across diverse disease models using spectral flow cytometry and high-dimensional analysis

Authors: Deepa Gautam, Emily M. Clarke, Rebecca L. Zon, Margaret R. Smith-Oliver, Avinash Kumar 5, Megan E. Sullivan, Panagiotis Karagiannis, Harvey G. Roweth, Elisabeth Battinelli

Read the Full Article on RPTH

RPTH

Stay updated on all scientific advances with Hemostasis Today.

Avinash Kumar 5 Deepa Gautam Elisabeth Battinelli Emily M. Clarke Harvey G. Roweth Health Hematology Hemostasis News Hemostasis Today Margaret R. Smith-Oliver Medicine Megan E. Sullivan Panagiotis Karagiannis platelets Rebecca L. Zon Research and Practice in Thrombosis and Haemostasis rpth RPTH Journal
NewsFeed